Pharmaceutical Sector

BUY Aurobindo Pharma with target Rs 985: Motilal Oswal

Malini Ranade 27 October 2020
BUY Aurobindo Pharma with target Rs 985: Motilal Oswal

Research house and brokerage Motilal Oswal has suggested BUY Call for pharmaceutical major Aurobindo Pharma with a target price of Rs 985.

Rakesh Jhunjhunwala and LIC Raise Stake in Lupin

Shalini Kakkad 14 October 2020
Rakesh Jhunjhunwala and LIC Raise Stake in Lupin

Ace investor Rakesh Jhunjhunwala has raised his stake in Lupin during the last quarter. Pharmaceutical sector has witnessed strong performance after COVID-19 pandemic led to lockdowns.

Wockhardt Signs Deal to Supply COVID-19 Vaccines to UK Government

Tulsi Deshmukh 3 August 2020
Wockhardt Signs Deal to Supply COVID-19 Vaccines to UK Government

Pharmaceutical major Wockhardt has signed a deal with the UK government to supply COVID-19 vaccine under development and testing by AstraZeneca and researchers from Oxford University.

Angel Broking: BUY Godrej Properties and Natco Pharma for Short Term

Shalini Kakkad 3 August 2020
Angel Broking: BUY Godrej Properties and Natco Pharma for Short Term

Angel Broking has suggested two BUY Call for short term investors.

Sanjiv Bhasin IIFL Securities: Lupin, Cipla, IPCA Labs, Cadila and Dr Lal Path Labs look interesting

Shalini Kakkad 23 July 2020
Sanjiv Bhasin IIFL Securities: Lupin, Cipla, IPCA Labs, Cadila and Dr Lal Path Labs look interesting

Market expert Sanjiv Bhasin has suggested five stocks for investors and medium-term outlook traders for August in the pharmaceutical segment.

DGCI sends Notice to Glenmark Pharmaceuticals over antiviral drug FabiFlu for COVID-19 Patients

Sukant Sharma 20 July 2020
DGCI sends Notice to Glenmark Pharmaceuticals over antiviral drug FabiFlu for COVID-19 Patients

Glenmark Pharmaceuticals has received a notice from the Drugs Controller General of India (DGCI) regarding pricing of antiviral drug FabiFlu that has been effective is recovery of some COVID-19 pat

Pages